The downgrade comes after the company reported full-year revenue that fell 4% below market expectations, reflecting an underperformance in the second half of the year.
Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA:ESLX) to "outperform," citing strong fundamentals and growth opportunities in the ophthalmology sector. Shares of the ...